Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Elkridge, Maryland Clinical Trials

A listing of Elkridge, Maryland clinical trials actively recruiting patient volunteers.

RESULTS

Found (6) clinical trials

Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults 65 Years of Age

Study of the safety and immunogenicity of 20vPnC and influenza vaccine administered at the same visit or separately

Phase

0.56 miles

Learn More »

Myasthenia Gravis Inebilizumab Trial

This study is a phase 3, randomized, double-blind, placebo-controlled study, to be conducted at approximately 100 study sites. Approximately 252 subjects (172 AChR-Ab+ and 80 MuSK-Ab+) will be enrolled. Patients with MG who are positive for anti-AChR or anti-MuSK antibodies will be enrolled and analyzed separately as 2 populations: (1) …

Phase

5.55 miles

Learn More »

Safety And Efficacy Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Complete Remission and Overall Survival In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

Myelodysplastic Syndrome (MDS) is a group of disorders that gradually affect the ability of a person's bone marrow (semi-liquid tissue present in many bones like backbones) to produce normal blood cells. Some people with MDS have a risk of the disease progressing to acute myeloid leukemia (AML), and a risk …

Phase

6.99 miles

Learn More »

Selpercatinib for the Treatment of Advanced Solid Tumors Lymphomas or Histiocytic Disorders With Activating RET Gene Alterations a Pediatric MATCH Treatment Trial

PRIMARY OBJECTIVE: I. To determine the objective response rate (ORR; complete response + partial response) in pediatric patients treated with selpercatinib (LOXO-292) with advanced solid tumors (including central nervous system [CNS] tumors), lymphomas or histiocytic disorders that harbor activating genetic alterations in the RET pathway. SECONDARY OBJECTIVES: I. To estimate …

Phase

9.44 miles

Learn More »

CD24Fc for the Prevention of Acute GVHD Following Myeloablative HSCT

The study is designed as a randomized, placebo-controlled, double blind, multicenter, phase III trial comparing two acute graft-versus-host disease (aGVHD) prophylaxis regimens: CD24Fc/tacrolimus / methotrexate (CD24Fc/Tac/MTX) versus placebo/tacrolimus / methotrexate (placebo/Tac/MTX) in the setting of myeloablative conditioning (MAC), matched unrelated donor (MUD) allogeneic hematopoietic stem cell transplantation in patients with …

Phase

9.44 miles

Learn More »

Post-Endoscopic Infection Rate Notifications to Improve the Delivery of Care

This project will notify centers of center's post-endoscopic infection rates and evaluate the effectiveness of this notification system to decrease infection rates. The investigators aim to notify centers of the number of patients and center's risk-adjusted rates of hospitalizations for infections after colonoscopy and esophagogastroduodenoscopy (EGD) procedures performed between January …

Phase N/A

9.54 miles

Learn More »